Antivert and Joint effusion - a phase IV clinical study of FDA data

Summary:

Joint effusion is reported as a side effect among people who take Antivert (meclizine hydrochloride), especially for people who are male, 60+ old, also take Lopressor, and have Haemorrhage.

The phase IV clinical study analyzes which people have Joint effusion when taking Antivert. It is created by eHealthMe based on reports of 3,935 people who have side effects when taking Antivert from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Joint effusion?

Joint effusion (presence of extra fluid in joint covering) is found to be associated with 872 drugs and 750 conditions by eHealthMe. Check the latest studies of Joint effusion.

On Jul, 15, 2026

3,935 people reported to have side effects when taking Antivert.
Among them, 17 people (0.43%) have Joint effusion.

Among these 17 people:

What is the gender of people who have Joint effusion when taking Antivert? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Joint effusion when taking Antivert? *

What are other drugs people take besides Antivert? *

What are other side effects people have besides Joint effusion? *

Weakness: 15 people, 88.24%
Back Pain: 13 people, 76.47%
Pain: 13 people, 76.47%
Stress And Anxiety: 13 people, 76.47%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 12 people, 70.59%
Cardiac Failure Congestive: 12 people, 70.59%
Spinal Osteoarthritis (joint cartilage loss in spine): 12 people, 70.59%
Dyspnea (difficult or laboured breathing): 11 people, 64.71%
Stable Angina (a constant chest pain): 11 people, 64.71%
Arrhythmias (irregular heartbeat): 10 people, 58.82%

What are the existing conditions these people have? *

Aortic Valve Incompetence: 8 people, 47.06%
High Blood Cholesterol: 8 people, 47.06%
Breast Cancer Metastatic: 8 people, 47.06%
Haemorrhage (bleeding): 8 people, 47.06%
Joint Pain: 5 people, 29.41%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 23.53%
Sleep Disorder: 3 people, 17.65%
Weight Loss: 3 people, 17.65%
Pain: 1 person, 5.88%
Neuralgia (pain in one or more nerves): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and have Joint effusion?

- Check whether Joint effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Antivert:

Antivert (4,087 reports)

Joint effusion treatments and more:

Joint effusion (9,947 reports)

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint effusion:

Joint effusion (872 drugs)

Browse all the conditions that are associated with Joint effusion:

Joint effusion (750 conditions)

Related publications that referenced our studies

Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride (the active ingredients of Antivert) and Antivert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.